Frequencies for first 10,000 rows of lit_ref variable in demo2018q2 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,368 93.68 93.68 , ALBERTSSON-LINDBLAD A, KOLSTAD A ,L.. | 1 0.01 93.69 , BELIN L, COTTU P, BONTEMPS P, LEMAN.. | 1 0.01 93.70 , BUDAI B, GANOFSZKY E, HORVATH Z, JU.. | 1 0.01 93.71 , CARTALAT-CAREL S, CHINOT O, BARRIE .. | 1 0.01 93.72 , CHAUVEAU A, BOYER-PERRARD F, GYAN E.. | 1 0.01 93.73 , DEMERET S, BOLGERT F, EYMARD B, LAF.. | 1 0.01 93.74 , DISTLER J, MAURER B, HUSCHER D, VAN.. | 1 0.01 93.75 , ECKBURG P, TALBOT G, LLORENS L AND .. | 1 0.01 93.76 , FONTANA R, RUSSO M, LEVITSKY J, YOS.. | 1 0.01 93.77 , FOX C, BODEN A, BLOOR A, DUNGAWALLA.. | 1 0.01 93.78 , GEORGALAS I, GIAVARAS G, ANASTASIOU.. | 1 0.01 93.79 , ISHIHARA M, MIYAHARA Y, TAMARU S, O.. | 1 0.01 93.80 , ISUPOVA E, CHIKOVA I, DUBKO M, MASA.. | 1 0.01 93.81 , JACKMAN J, MCSHERRY F, HERNDON J, M.. | 1 0.01 93.82 , JAOVISIDHA S AND VILAIYUK S. LONG-T.. | 1 0.01 93.83 , KAKURAI K, SUZUKI H, ISHIZAKI E, KI.. | 1 0.01 93.84 , KATO M, TANAKA Y, INOO M, KOBAYASHI.. | 1 0.01 93.85 , KOTOULA V, GIANNOULATOU E, KOLIOU G.. | 1 0.01 93.86 , MASUHARA H, KURIHARA A, SHIOKAWA H,.. | 1 0.01 93.87 , MCCALL L, MUSS H, JATOI A, COHEN H,.. | 1 0.01 93.88 , MELO M, GONCALVES J, NEVES M, SANTA.. | 1 0.01 93.89 , MURO K, MORITA S, IWASA S, HAN S, W.. | 1 0.01 93.90 , NIKOLAOU M, KALBAKIS K, POLYZOS A, .. | 1 0.01 93.91 , OKUYAMA T, UCHIDA J, NISHINO K, KUM.. | 1 0.01 93.92 , OLIVEIRA A, FERREIRA P, RESENDE M, .. | 1 0.01 93.93 , PARK J, JUNG Y, KIM D, LEE J, SONG .. | 1 0.01 93.94 , PIROGOVA O, ALYANSKI A, BABENKO E, .. | 1 0.01 93.95 , PLUARD T, URRUTICOECHEA A, FARCI D,.. | 1 0.01 93.96 , RESCHE-RIGON M, COMARMOND C; SORIAN.. | 1 0.01 93.97 , ROMAGUERA J, SROUR S, LEE H, HAGEME.. | 1 0.01 93.98 , SANTIAGO, P. BRENT, M. THIRD NERVE .. | 1 0.01 93.99 , SHAH A, SANTA-MARIA C, SIZIOPIKOU K.. | 1 0.01 94.00 , SYN N, LEE S, WANG L, LIM X, LOH M,.. | 1 0.01 94.01 , TSURUTANI J, TAKAHASHI M, YAMANAKA .. | 1 0.01 94.02 , VARRASSO G, COLLINI P AND CLERICO A.. | 1 0.01 94.03 , VICI P, BELLI F, TOMAO S, FATTORUSO.. | 1 0.01 94.04 , WARREN D, HURT C, AZNAR M, PARTRIDG.. | 1 0.01 94.05 , WU I, SANCHEZ J, MAIA M, SARAVIA M,.. | 1 0.01 94.06 , WU X, BAI Y, GAO Y, JIANG W, KONG L.. | 1 0.01 94.07 . FIRST-LINE AND MAINTENANCE TREATMEN.. | 1 0.01 94.08 . FIRST-LINE AND MAINTENANCE TREATMEN.. | 1 0.01 94.09 . RITUXIMAB AS FIRST-LINE AND MAINTEN.. | 1 0.01 94.10 1) PATEL H, DEPASQUALE J. TETANY SECO.. | 1 0.01 94.11 ACOSTA F, ODDINO J, BENITEZ ML, LEMA .. | 1 0.01 94.12 ACOSTA F, ODDINO J, BENITEZ ML, LEMA .. | 3 0.03 94.15 AGGARWAL, N.. A RARE CASE OF CHB, SEV.. | 1 0.01 94.16 AGULNIK A, KELLY DP, BRUCCOLERI R, YU.. | 1 0.01 94.17 AHMED H, ALI H. RISPERIDONE INDUCED W.. | 1 0.01 94.18 AJAM S, GARLIE J, JEFFREY M, DEEPAK B. | 1 0.01 94.19 AJAM S, GARLIE JB, MOSSIER JR, BHAKTA.. | 1 0.01 94.20 AJAM S, JASON B, JEFFREY R, DEEPAK B. | 1 0.01 94.21 AKASAKA M, SAKAMOTO M, ZHANG L, ET AL.. | 1 0.01 94.22 AKBOGA M, CANPOLAT U, AKYEL A, ARAS D.. | 1 0.01 94.23 AL-ALOUL M, MILLER H, STOCKTON P, LED.. | 1 0.01 94.24 AL-KHINJI AISHA. SPLENIC INFARCTION A.. | 1 0.01 94.25 ALBERTI-VIOLETTI S, VEZZOLI P, CORTI .. | 1 0.01 94.26 ALCAZAR-VILADOMIU ED, TUNEU-VALLS A, .. | 1 0.01 94.27 ALCAZAR-VILADOMIU ED, TUNEU-VALLS A, .. | 1 0.01 94.28 ALIMENA G, BRECCIA M, MANCINI M, FERR.. | 1 0.01 94.29 ALIMENA, G.. ACUTE LEUKEMIA PRESENTIN.. | 1 0.01 94.30 ANNIBALI O, CHIODI F, CENFRA N, SARLO.. | 1 0.01 94.31 AOYAGI, I.. A CASE OF ACUTE AORTIC DI.. | 1 0.01 94.32 ARELLANO A, MARTIN-SUBERO M, MONERRIS.. | 1 0.01 94.33 ARELLANO AL, MARTIN M, MONERRIS M, LL.. | 1 0.01 94.34 ARELLANO AL, MARTIN-SUBERO M, MONERRI.. | 1 0.01 94.35 ARUCH, D.. SIMULTANEOUS PRES AND TMA .. | 1 0.01 94.36 ASAI S,TAKUYUKI KATABAMI, SHIN KAWANA.. | 1 0.01 94.37 ATEFI D, PINTO SANDER N, RICHARDSON D.. | 1 0.01 94.38 ATTAL M. LENALIDOMIDE MAINTENANCE AFT.. | 1 0.01 94.39 AUTORE F, INNOCENTI I, D ARENA G, COS.. | 1 0.01 94.40 AUTORE F, INNOCENTI I, DARENA G, COSC.. | 1 0.01 94.41 AVERY LM, ZEMPEL M, WEISS E.. CASE OF.. | 1 0.01 94.42 AWORTWE C, MAKIWANE M, REUTER H, MULL.. | 1 0.01 94.43 AYA TAKAHASHI. EARLY NIGHT OF REVOLUT.. | 1 0.01 94.44 AZUMA C, KYAN R, YAMANAKA A, ET AL. A.. | 1 0.01 94.45 B M, M M, R C, B P. OCCURRENCE OF THR.. | 1 0.01 94.46 BAIRD P, LEUNG S, HOANG H, BABALOLA O.. | 1 0.01 94.47 BALAKIRSKI G, NEIS M, MEGAHED M. ACNE.. | 1 0.01 94.48 BANERJEE R, TIMLIN C, FITZPATRICK D, .. | 1 0.01 94.49 BANERJEE SN, OZA AM, HAMILTON EP, HAS.. | 1 0.01 94.50 BARATTA J, DYCK J, BRAND P, THAISETTH.. | 1 0.01 94.51 BEBAWI E; JOUNI SS; TESSIER A-A; FREN.. | 1 0.01 94.52 BENE J, AUFFRET M, POTEY C, GAUTIER S.. | 1 0.01 94.53 BERGER JR, CREE BA, GREENBERG B, HEMM.. | 1 0.01 94.54 BERMAN AJ, KESSLER BD, SUD P, NOGAR J.. | 1 0.01 94.55 BERMAN AJ, KESSLER BD, SUD P, NOGAR J.. | 1 0.01 94.56 BERNAL L, ESTEVEZ B. CORNEAL TOXICITY.. | 1 0.01 94.57 BERNHARDT P, DONG G, LOPEZ P, HUSTACH.. | 2 0.02 94.59 BEYER G, KUSTER I, BUDDE C, WILHELM E.. | 1 0.01 94.60 BINAGHI G, CONGIA D, COSSA S, MASSIDD.. | 1 0.01 94.61 BLANCO A, GIGER-PABST U, SOLASS W, ZI.. | 1 0.01 94.62 BONDON-GUITTON E, EGRON A, OLIVIER-AB.. | 1 0.01 94.63 BONNET, U.. ON THE RISK OF DEPENDENCE.. | 1 0.01 94.64 BOSTROM I, KRISTOFFERSSON A, BOSTROM .. | 2 0.02 94.66 BOUILLON A-S, BEIER F, FERREIRA MS, K.. | 1 0.01 94.67 BOUILLON A-S, BEIER F, FERREIRA MS, K.. | 1 0.01 94.68 BRAGA CCB, BENITES BD, ALBUQUERQUE DD.. | 1 0.01 94.69 BRECCIA M, LATAGLIATA R, CARMOSINO I,.. | 1 0.01 94.70 BROMLEY RL, MAWER G, CLAYTON-SMITH J,.. | 1 0.01 94.71 BROMLEY RL, MAWER G, CLAYTON-SMITH J,.. | 1 0.01 94.72 BRUNO G, FABRIZIO C, MILANO E, DELL^A.. | 2 0.02 94.74 BUCHHOLZ S, DAMMANN E, STADLER M, KRA.. | 1 0.01 94.75 BUCHHOLZ S, DAMMANN E, STADLER M, KRA.. | 1 0.01 94.76 BUCHHOLZ S, DAMMANN E, STADLER M, KRA.. | 1 0.01 94.77 CAO, X.. CENTRAL ANTICHOLINERGIC SYND.. | 1 0.01 94.78 CARDONICK, E.. MATERNAL AND FETAL OUT.. | 1 0.01 94.79 CENTOLA, M.. A RARE CASE OF LARGE INT.. | 1 0.01 94.80 CHADLY Z, ZAIEM A, SAHNOUN R LAKHOUA.. | 1 0.01 94.81 CHAM, S.. MOOD, PERSONALITY, AND BEHA.. | 1 0.01 94.82 CHANG F, MAHANT N, FUNG V, TSUI D, AL.. | 1 0.01 94.83 CHAVAN T, D^COSTA D. A RARE CASE OF D.. | 1 0.01 94.84 CHEN JR; BUCHMILLER BL; KHAN DA. AN H.. | 1 0.01 94.85 CHERRIER-DE WILDE S, RACK K, VANNUFFE.. | 1 0.01 94.86 CHUA C, TAN I, YAMADA Y, RHA S, YONG .. | 1 0.01 94.87 CHUA C, TAN I, YAMADA Y, RHA S, YONG .. | 2 0.02 94.89 CHUA C, TAN I, YAMADA Y, RHA S, YONG .. | 1 0.01 94.90 CHUA C, TAN I, YAMADA Y, RHA S, YONG .. | 1 0.01 94.91 CHUDO M, FERGUSON K. A CASE OF SEVERE.. | 1 0.01 94.92 CHUDOW M, FERGUSON K. 1879: SEVERE, R.. | 1 0.01 94.93 CHUDOW M, FERGUSON K.. A CASE OF SEVE.. | 1 0.01 94.94 CHUDOW, M.. A CASE OF SEVERE, REFRACT.. | 1 0.01 94.95 CIAMMELLA P, FILIPPI A, SIMONTACCHI G.. | 1 0.01 94.96 CIRIONI O, WEIMER LE, FRAGOLA V, GIAC.. | 1 0.01 94.97 COIRIER V., LESCOAT A., CHABANNE C., .. | 1 0.01 94.98 COIRIER V.,LESCOAT A.,CHABANNE C.,FOU.. | 1 0.01 94.99 COLE ET AL J. WIDE COMPLEX TACHYCARDI.. | 1 0.01 95.00 COLOMBIER MA, ALANIO A, DENIS B, MELI.. | 1 0.01 95.01 CONNER CD, MCKENZIE E, OWEN CE, CALLE.. | 1 0.01 95.02 COORAY SD, WORSLEY RN, SZTAL-MAZER S,.. | 1 0.01 95.03 CORDOBA TORRES IT, MARINO-NIETO J, BA.. | 1 0.01 95.04 CORNISH, K.. INTRAVITREAL BEVACIZUMAB.. | 1 0.01 95.05 CUNY P, HOUOT M, GINISTY S, HOROWICZ .. | 1 0.01 95.06 CUNY P, HOUOT M, GINISTY S, HOROWICZ .. | 1 0.01 95.07 DE GEUS H, MATHOT R, VAN DER HOVEN B,.. | 1 0.01 95.08 DEJOU-BOUILLET L, BOURDEL N, SLIM K, .. | 1 0.01 95.09 DELIA, M.. FUSARIOSIS IN A PATIENT WI.. | 1 0.01 95.10 DELJEHIER T, PARIENTE A, MIREMONT-SAL.. | 1 0.01 95.11 DELYON, JULIE. KERATINOCYTE DYSTROPHY.. | 1 0.01 95.12 DEMARTINI B, D^ AGOSTINO A, BASI C, G.. | 1 0.01 95.13 DESCOEUR J, PHILIBERT L, CHALARD K, E.. | 1 0.01 95.14 DI MAIO VC, CENTO V, LENCI I, ARAGRI .. | 1 0.01 95.15 DOI, K.. USE EXPERIENCE OF PAZOPANIB .. | 1 0.01 95.16 DOI: 10.14744/EPILEPSI.2017.70783#. K.. | 1 0.01 95.17 DOI: 10.5301/TJ.5000312#. TABERNER BO.. | 1 0.01 95.18 DOI:10.1097/MBC.0000000000000726 MING.. | 2 0.02 95.20 DORIA A,BAJOCCHI G, TONON M, SALVARAN.. | 1 0.01 95.21 DUMANLI OZCAN A, OZCAN E, CANAKCI E, .. | 1 0.01 95.22 ECKERT S, WEINSTOCK-GUTTMAN B, HOJNAC.. | 1 0.01 95.23 EFFERTH T, SCHOTTLER U, KRISHNA S, ET.. | 1 0.01 95.24 EFFERTH T, SCHOTTLER U, KRISHNA S, SC.. | 1 0.01 95.25 EFFERTH T, SCHOTTLER U, KRISHNA S, SC.. | 1 0.01 95.26 EFFERTH T, SCHOTTLER U, KRISHNA S, SC.. | 1 0.01 95.27 EFFERTH T, SCHTTLER U, KRISHNA S, SCH.. | 1 0.01 95.28 EHRET M, VELTER C, TEBACHER M, BRUANT.. | 1 0.01 95.29 ELISAF, M. DISORDERS OF POTASSIUM HOM.. | 1 0.01 95.30 ETHEMOGLU F, KAVALCI G, BATUMAN A, AK.. | 1 0.01 95.31 ETHEMOGLU FB, KAVALCI G, BATUMAN A, A.. | 1 0.01 95.32 EYAL A, BRAUN E, NAFFAA M. SYNCOPE CA.. | 1 0.01 95.33 FERNANDEZ-FERREIRO, A.. SEROTONIN SYN.. | 1 0.01 95.34 FINK A, BAHLO J, ROBERCHT S, AL-SAWAF.. | 1 0.01 95.35 FOLLOWS G. LBRUTINIB FOR RELAPSED/REF.. | 1 0.01 95.36 FORGER F, ZBINDEN A, VILLIGER PM. CER.. | 1 0.01 95.37 FUJI Y, HIRAHARA N, KAJI S, TANIURA T.. | 1 0.01 95.38 FUJII K, KUNIHIRO M, KOSAKA M, HIRATA.. | 1 0.01 95.39 FUKUDA R, YOSHIDA H, TANIGUCHI H, SAI.. | 1 0.01 95.40 FUKUDA Y, KAGA M, IKEDA S. A CASE OF .. | 1 0.01 95.41 FUKUDA, R; YOSHIDA, H; TANIGUCHI, H; .. | 1 0.01 95.42 FULLERTON, T.. A PHASE 2 CLINICAL TRI.. | 1 0.01 95.43 FUWA, K.. RETINOPATHY OF PREMATURITY .. | 1 0.01 95.44 GAJJAR K, HIRAPARA H, JAISWAL CS, BAR.. | 1 0.01 95.45 GALANI M, ET AL.. PATIENT WITH HEART .. | 1 0.01 95.46 GAMBACORTI PASSERINI, C.. LONG-TERM E.. | 1 0.01 95.47 GAMBHIR IS, KAUR U, CHAKRABARTI SS. Z.. | 1 0.01 95.48 GARZON J, BOKHARI H, WANG J. RIFAMPIC.. | 1 0.01 95.49 GENEVI?VE C. DIGBY, ANDR?S RICARDO P?.. | 1 0.01 95.50 GERACE, E.. DRUG INTOXICATION: CASE R.. | 1 0.01 95.51 GEURTSEN M, KORS W, MOLL A, SMITS C. .. | 1 0.01 95.52 GIAGNUOLO G, BUFFARDI S, MARCHESE L, .. | 1 0.01 95.53 GIBSON, BES.. TREATMENT STRATEGY AND .. | 1 0.01 95.54 GILADI Y, IOSCOVICH A,. HYPOTHERMIA F.. | 1 0.01 95.55 GIONA F, PUTTI MC, MICALIZZI C, MENNA.. | 1 0.01 95.56 GIRASOLE F, PICCOLO G, TIMPANELLI R, .. | 1 0.01 95.57 GOLD R, ARNOLD D, BAR-OR A, HUTCHINSO.. | 1 0.01 95.58 GOLOMB, B.. FLUOROQUINOLONE-INDUCED S.. | 1 0.01 95.59 GRAHAM LM, YANTA JH. AN UNUSUAL METHO.. | 1 0.01 95.60 GRANDE-MARTIN A, PARDAL-FERNANDEZ J, .. | 1 0.01 95.61 GRUENBERG J, MANIVEL JC, GUPTA P, DYK.. | 1 0.01 95.62 GUVENIR H, MISIRLIOGLU ED, VEZIR E, T.. | 1 0.01 95.63 GYBEL, M. AND AL.. CARDIAC ARREST CAU.. | 1 0.01 95.64 HAAG L, HOFMANN J, KREDEL L, HOLZEM C.. | 1 0.01 95.65 HAAG LM, HOFMANN J, KREDEL LI,. HERPE.. | 1 0.01 95.66 HABETS, J.. SERIOUS AND REVERSIBLE LE.. | 1 0.01 95.67 HAGOP M KANTARJIAN. INOTUZUMAB OZOGAM.. | 1 0.01 95.68 HAKKINEN, M.. PROFILES OF PREGABALIN .. | 3 0.03 95.71 HALABY, A.. PREGABALIN DEPENDENCE: A .. | 1 0.01 95.72 HAMADAH A,BEAULIEU L,WILSON J,AKSAMIT.. | 1 0.01 95.73 HAMM, C.E.. GABAPENTIN CONCENTRATIONS.. | 1 0.01 95.74 HANRATH MA, SWART EL. CONVULSIONS DUE.. | 1 0.01 95.75 HANSEN A, ENGELHARDT L, PLESCHUTZNIG .. | 1 0.01 95.76 HASEGAWA C, KUDO M, MARUYAMA H, KIMUR.. | 1 0.01 95.77 HASIJA RP, SILVERMAN ED, CHO S, FUNG .. | 1 0.01 95.78 HATEGAN A, BOURGEOIS JA. DONEPEZIL-AS.. | 1 0.01 95.79 HAZEM ASSI. INCIDENCE OF FEBRILE NEUT.. | 1 0.01 95.80 HE Y ET AL.. ONE CASE OF ADEFOVIR DIP.. | 1 0.01 95.81 HENSLEY MD, BEBARTA VS, BORYS DJ. A L.. | 1 0.01 95.82 HENSLEY, M.. A LARGE CASE SERIES OF A.. | 1 0.01 95.83 HERNANDEZ LAIN A, HILARIO A, SEPULVED.. | 1 0.01 95.84 HERZOG, J. TRABECTEDIN FOLLOWED BY IR.. | 1 0.01 95.85 HICKEY, P.. BOSUTINIB THERAPY RESULTI.. | 1 0.01 95.86 HIDAKA N, TAGUCHI M. 6 CASES OF RS3PE.. | 1 0.01 95.87 HIERONIMUS A., KLEIN R., HARING HU., .. | 1 0.01 95.88 HIGASHI? D. WS2-02: REVIEWING CASES .. | 1 0.01 95.89 HILL F. FROM A FISH TANK INJURY TO HO.. | 1 0.01 95.90 HIROHATA, T.. A CASE OF ACROMEGALY IN.. | 1 0.01 95.91 HIROSHI SUZUKI, ET AL.. A CASE OF 80 .. | 1 0.01 95.92 HIRSCHI S., BIONDINI D., OHANA M., SO.. | 1 0.01 95.93 HLEYHEL M, GOUJON S, DELTEIL C, VASIL.. | 1 0.01 95.94 HOKAO K. THE 51ST ANNUAL MEETING OF J.. | 1 0.01 95.95 HONDA Y, ATSUSHI O, GYOHEI E, YUTAKA .. | 1 0.01 95.96 HORIE S, NISHIDA H, SUENAGA S, KANNO .. | 1 0.01 95.97 HOTAKA YAMADA, ET.AL. A CASE OF A PAT.. | 1 0.01 95.98 HOVANCAKOVA J, SCHORETSANITIS G, SCHO.. | 1 0.01 95.99 HUSAIN NS, GOLDMAN P, GOLDRATH K, MAL.. | 1 0.01 96.00 HUSSAIN N. A CASE OF AIRWAY COMPROMIS.. | 1 0.01 96.01 HUSSAIN SA, PALMER DH, LLOYD B, COLLI.. | 1 0.01 96.02 ICHIMASU N, FURUKAWA Y, YAMAZAKI M, E.. | 1 0.01 96.03 IIDA T, WAGATSUMA K, TANI M, SASAKI H.. | 1 0.01 96.04 IIDA T, WAGATSUMA K, TANI M, SASAKI H.. | 1 0.01 96.05 IIDA T, WAGATSUMA K, TANI M, SASAKI H.. | 1 0.01 96.06 IIDA T, WAGATSUMA K, TANI M, SASAKI H.. | 1 0.01 96.07 IIDA T, WAGATSUMA K, TANI M, SASAKI H.. | 1 0.01 96.08 IMACHI K, KAWAHARA D, IKEBE A, TADA N.. | 1 0.01 96.09 IMAI MIYUU, OGATA KENICHI, NAMATA GIM.. | 1 0.01 96.10 INAGAKI N, GODA M, YOKOTA S, MARUYAMA.. | 1 0.01 96.11 INNOCENTI I, ALBERELLI MA, AUTORE F, .. | 1 0.01 96.12 IRMAK I, ERNAM D, AKTURK UA, KABADAYI.. | 1 0.01 96.13 ISAKOFF S, WANG D, CAMPONE M, CALLES .. | 1 0.01 96.14 ISHIBUCHI, H.. A CASE OF METHOTREXATE.. | 1 0.01 96.15 ITO, H.. THE TREATMENT OF COEXISTING .. | 1 0.01 96.16 ITO, IZUMI. A CASE OF IGA VASCULITIS .. | 1 0.01 96.17 JACOBS L, VAN DER VLIES E, TEN BOKKEL.. | 1 0.01 96.18 JACOBS REA, GU P, CHACHOUA A. REACTIV.. | 1 0.01 96.19 JACOBSEN A, PAPO Y, SARRO R, WEISSE K.. | 1 0.01 96.20 JACOBSEN AA, PAPO YB, SARRO R, WEISSE.. | 1 0.01 96.21 JACOBSEN AA, PAPO YB, SARRO R, WEISSE.. | 1 0.01 96.22 JAEKEL N, HUBERT K, KRAHL R, HAENEL M.. | 1 0.01 96.23 JAIN, G.. SEROTONIN SYNDROME: A CASE .. | 1 0.01 96.24 JAMES A, LARSON T. ACUTE RENAL FAILUR.. | 1 0.01 96.25 JAMES, A.. ACUTE RENAL FAILURE AFTER .. | 1 0.01 96.26 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 1 0.01 96.27 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 1 0.01 96.28 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 1 0.01 96.29 JUSUFBEGOVIC D, SCHAAL S. QUIESCENT H.. | 1 0.01 96.30 KACZMARSKA-TUREK D, BARTNIK P, KACPER.. | 1 0.01 96.31 KAICHI NISHIWAKI. TWO CASES OF CEREBR.. | 1 0.01 96.32 KANEMATSU R, KIMURA T, ICHIKAWA Y AND.. | 1 0.01 96.33 KANG B, CHOIA S, KIM HS, KIM K, LEE Y.. | 1 0.01 96.34 KANG M, GUPTA R, DAWISKIBA M, PINCUS .. | 1 0.01 96.35 KANG M, GUPTA R, SRINIVASAN J. PERIPH.. | 1 0.01 96.36 KANG M, GUPTA R, SRINIVASAN J. PERIPH.. | 1 0.01 96.37 KANG MK, GUPTA RK, SRINIVASAN J. PERI.. | 1 0.01 96.38 KARAHASANOVIC A, THORSTEINSSON AL, BJ.. | 1 0.01 96.39 KARRIS MY.. RESOLUTION OF TENOFOVIR D.. | 1 0.01 96.40 KARVUNIDIS T, HARAZIM M, RADEJ J, NOV.. | 1 0.01 96.41 KASENDA B, IHORST G, SCHROERS R, KORF.. | 1 0.01 96.42 KATSIMPRIS JM, KATSIMPRIS A, THEOULA.. | 1 0.01 96.43 KATSUMATA H, YAMAMOTO I, KOMATSUZAKI .. | 1 0.01 96.44 KATSUMI EGUCHI, ET AL. MANAGEMENT OF .. | 1 0.01 96.45 KATSURAGI T, IWASHIGE A, TSUKADA J. I.. | 1 0.01 96.46 KAUR U, CHAKRABARTI SS, GAMBHIR IS. I.. | 1 0.01 96.47 KAWAE D, ET AL. A CASE OF LUNG ADENOC.. | 1 0.01 96.48 KAYA S, AY N, BAYSAL B, COMOGLU S. P-.. | 1 0.01 96.49 KAZUHIRO O., TOYOHIRO K., YUTAKA Y., .. | 1 0.01 96.50 KAZUYA S, MAEDA T, KURIYAMA A, SHIMAD.. | 1 0.01 96.51 KEN HOSHIYAMA, ET AL.. A CASE OF HEPA.. | 1 0.01 96.52 KHALID, M.. DOCETAXEL INDUCED PULMONA.. | 1 0.01 96.53 KHALID, Z.. CELERY ROOT EXTRACT AS AN.. | 1 0.01 96.54 KIKUCHI Y, ET AL.. 23RD ANNUAL MEETIN.. | 1 0.01 96.55 KIMOTO M, YAMAGUCHI N, MARUO M., ET A.. | 1 0.01 96.56 KING G, BYRNE A, FLEMING P. A CASE OF.. | 1 0.01 96.57 KING, G.. A CASE OF SEVERE NSAID EXAC.. | 1 0.01 96.58 KINNUNEN U, FARKKILA M, MAKISALO H. A.. | 1 0.01 96.59 KINTZ, P.. ASSESSMENT OF PREGABALIN U.. | 1 0.01 96.60 KINTZ, P.. ASSESSMENT OF PREGABALIN U.. | 1 0.01 96.61 KNEPPERS E, VAN DER HOLT B, KERSTEN M.. | 1 0.01 96.62 KNOLL, K.. MUCOCUTANEOUS ULCERATIONS .. | 1 0.01 96.63 KOCH HJ. SEVERE QUETIAPINE WITHDRAWAL.. | 1 0.01 96.64 KOIKE Y, SAISHO Y, OSHIMA Y, HORIUCHI.. | 1 0.01 96.65 KOLOMEYER A M, KODATI S.. LAMOTRIGINE.. | 1 0.01 96.66 KOLOMEYER A, KODATI S. LAMOTRIGINE-IN.. | 1 0.01 96.67 KONDO N, YODA T, FUJISAWA J, ARAI K, .. | 1 0.01 96.68 KOSCHNY, R.. EXTRACORPOREAL LIFE SUPP.. | 1 0.01 96.69 KOUKLAKIS G, EFREMIDOU EI, ZEZOS P, L.. | 1 0.01 96.70 KOVACH, J.. GEMCITABINE-INDUCED RETIN.. | 1 0.01 96.71 KRASTEV Z, JELEV D, ANTONOV K, PETKOV.. | 1 0.01 96.72 KRIIKKU P, OJANPERA I. THE RELATIONSH.. | 1 0.01 96.73 KUCHAREWICZ I, KEMONA-CHETNIK I, REDU.. | 1 0.01 96.74 KUMAR KA, KAR R, JACOB SE, BASU D, DU.. | 1 0.01 96.75 KUNIMOTO, M.. D-HCM PATIENT WITH LEFT.. | 1 0.01 96.76 KURIMOTO C. A STUDY ON ENDOCRINE-ADVE.. | 1 0.01 96.77 KURONO K, KAWASHIMA T. A CASE OF POST.. | 1 0.01 96.78 LANOY C, BOUCKAERT Y. METABOLIC ACIDO.. | 1 0.01 96.79 LAROCHELLE C, SERAFINI B, ZANDEE S, R.. | 1 0.01 96.80 LAURENTI L, AUTORE F, INNOCENTI I, DA.. | 1 0.01 96.81 LE G, LE GUERN A, LEBAS D, THILLARD E.. | 1 0.01 96.82 LE VAILLANT, J. ACETAMINOPHEN (PARACE.. | 1 0.01 96.83 LEE S, WOO S, PARK K, KIM J, SONG J, .. | 1 0.01 96.84 LEE S, WOO S, PARK K, KIM J, SONG J, .. | 1 0.01 96.85 LIBBRECHT, C.. GH INJECTION-SITE SARC.. | 1 0.01 96.86 LING J, BUURMAN D, RAVIKUMARA M, MEWS.. | 1 0.01 96.87 LINK A, KAPLAN BT, BOHM M.. 21-YEAR-O.. | 1 0.01 96.88 LIZARRAGA A, LIZARRAGA K, HOFFMAN J, .. | 1 0.01 96.89 LONATI, D.. PERIDURAL ACCIDENTAL ADMI.. | 1 0.01 96.90 LUMINARI S, VIEL E, FERRERI A, ZAJA F.. | 1 0.01 96.91 LUTZ M, SCHULZE A, REBBER E, WIEBE S,.. | 1 0.01 96.92 MADOKA S, KITAHASHI M, YOKOUCHI H, BA.. | 1 0.01 96.93 MAEDA C, ET AL..THERAPY-RELATED MYELO.. | 1 0.01 96.94 MAEDA C.THERAPY-RELATED MYELODYSPLAST.. | 1 0.01 96.95 MAEDA S, ET AL.. A CASE OF MULTIPLE A.. | 1 0.01 96.96 MANCANO MA. HIGH-DOSE LOPERAMIDE ABUS.. | 1 0.01 96.97 MANDIGERS, L.. SEVERE VERAPAMIL INTOX.. | 1 0.01 96.98 MANDIGERS, L.. SEVERE VERAPAMIL INTOX.. | 1 0.01 96.99 MANEA E, STEFAN I, OLARIU C, ET AL. A.. | 1 0.01 97.00 MANKAD S, KARTHIK R, RUPALI P, MICHAE.. | 1 0.01 97.01 MANSO L, VALBUENA T, PADIAL MA, RECHE.. | 1 0.01 97.02 MARIETTE, X.. LYMPHOMA IN THE TOFACIT.. | 4 0.04 97.06 MARIETTE, X.. LYMPHOMA IN THE TOFACIT.. | 4 0.04 97.10 MARIETTE, XAVIER. LYMPHOMA IN THE TOF.. | 1 0.01 97.11 MARINO K, SANTIAGO R, DEW R, BERLINER.. | 1 0.01 97.12 MARRAFFA JM, HOLLAND MG, SULLIVAN .. | 1 0.01 97.13 MARTIN-NAVARRO, J.. ACUTE RENAL FAILU.. | 1 0.01 97.14 MARUYAMA M, KENMOCHI T, ASANO T, SAIG.. | 1 0.01 97.15 MASUNAGA T. SHIRAISHI K, YATSUKA K, E.. | 1 0.01 97.16 MATSUI S. PROGRESS OF DIGESTIVE ENDOS.. | 1 0.01 97.17 MATSUOKA H. A CASE OF RHEUMATOID ARTH.. | 1 0.01 97.18 MATSUSHITA, M.. A CASE IN WHICH MEDIC.. | 1 0.01 97.19 MATTA A, ASSALIE NA, GUPTA RK, DEL PI.. | 1 0.01 97.20 MAZHAR F, AKRAM S. ACUTE RENAL DAMAGE.. | 1 0.01 97.21 MEDANI S, WALL C. COLCHICINE TOXICITY.. | 1 0.01 97.22 MEDANI S, WALL C.. COLCHICINE TOXICIT.. | 1 0.01 97.23 MEDANI S, WALL C.. COLCHICINE TOXICIT.. | 1 0.01 97.24 MEDANI SM, WALL C. COLCHICINE TOXICIT.. | 1 0.01 97.25 MICHELS, G.. LIFE-THREATENING CARDIAC.. | 1 0.01 97.26 MILOJKOVIC D, SHORT K, SALISBURY JR, .. | 1 0.01 97.27 MIURA M, MASAHIRO MIRU AT AL. UNKNOWN.. | 1 0.01 97.28 MORGAN R, DOLENC T. ESCITALOPRAM-INDU.. | 1 0.01 97.29 MORI A.. A CASE OF HYPERCALCAEMIA OF .. | 1 0.01 97.30 MORI H, TAKAYA H, NAMISAKI T, NOGUCHI.. | 1 0.01 97.31 MORITA K, KOYA J, TOYA T, NAKAMURA F,.. | 1 0.01 97.32 MORITA K, KOYA J, TOYA T, NAKAMURA F,.. | 1 0.01 97.33 MORITA, R.. THROMBOTIC MICROANGIOPATH.. | 1 0.01 97.34 MOTTA, I.. A PROBABLE DRUG-TO-DRUG IN.. | 1 0.01 97.35 MOUFFAK A, GILSON M, LEPELLEY M, ALLE.. | 1 0.01 97.36 MOZZICONACCI MJ, CAILLERES S, MAURICE.. | 1 0.01 97.37 MULLER-HANSMA A, DAEMEN -GUBBELS C, S.. | 1 0.01 97.38 MURTAZA A, ALI H, NAIR B, AHMED AK.. .. | 1 0.01 97.39 NAGATA, Y.. SUCCESSFUL TREATMENT OF A.. | 1 0.01 97.40 NAITO Y, SONOBE S, KAWAGUCHI M, ET AL.. | 1 0.01 97.41 NAKAHARAI K, SAKAMOTO Y, YAITA K, YOS.. | 3 0.03 97.44 NAKANO T, KOBAYASHI D, ITO S, TAKAI C.. | 1 0.01 97.45 NALEZINSKA M.. TREATMENT OF EPISODE O.. | 1 0.01 97.46 NANIWA T. A CASE OF RHEUMATOID ARTHRI.. | 1 0.01 97.47 NAOTO TAKAHASHI, CHIAKI NAKASEKO, KAI.. | 1 0.01 97.48 NAPOLITANO MADDALENA. MULTIPLE SCLERO.. | 1 0.01 97.49 NAVARRO JT, FELIU E, GRAU J, COLOMER .. | 2 0.02 97.51 NDAGIJE H, NAMBASA V, NAMAGALA E, NAS.. | 1 0.01 97.52 NEDAHL M, JOHANSEN SS, LINNET K. REFE.. | 1 0.01 97.53 NGUYEN PVQ, SPINELLI C. PRESCRIBING C.. | 1 0.01 97.54 NGUYEN T, CAUGHEY G, PRATT N, SHAKIB .. | 1 0.01 97.55 NGUYEN T, CAUGHEY G, PRATT N, SHAKIB .. | 1 0.01 97.56 NGUYEN T.A.. HOSPITALIZATION FOR DRUG.. | 1 0.01 97.57 NGUYEN TA, CAUGHEY G, PRATT N, SHAKIB.. | 1 0.01 97.58 NGUYEN, T.. HOSPITALIZATION FOR DRUG-.. | 1 0.01 97.59 NICOLATOU-GALITIS O, RAZIS E, GALITI .. | 1 0.01 97.60 NICOLATOU-GALITIS, O.. PERIODONTAL DI.. | 1 0.01 97.61 NIETO Y ET AL. HIGH-DOSE INFUSIONAL G.. | 1 0.01 97.62 NIETO Y, VALDEZ BC, THALL PF, JONES R.. | 2 0.02 97.64 NIETO Y, VALDEZ BC, THALL PF, JONES R.. | 2 0.02 97.66 NIKLAS, K.. POLYMYOSITIS INDUCED BY A.. | 1 0.01 97.67 NISHII M. TWO CASES OF TUMOR LYSIS SY.. | 1 0.01 97.68 NOESSLINGER T, PANNY M, MOESTL M, KOL.. | 1 0.01 97.69 NORIKO SHUZENJI, ET AL.. A CASE OF LI.. | 1 0.01 97.70 NORITAKA O, JUN S, TAKUYA A, ET AL.. .. | 1 0.01 97.71 NORMAN H, ELFINEH M, BEIJER E, CASSWA.. | 1 0.01 97.72 NORMAN H, ELFINEH M, BEIJER E, CASSWA.. | 1 0.01 97.73 NORMAN H, ELFINEH M, BEIJER E, ET AL... | 1 0.01 97.74 OFFIDANI M, CORVATTA L, LIBERATI A, P.. | 1 0.01 97.75 OGUZ, H.. SILDENAFIL-ASSOCIATED VASCU.. | 1 0.01 97.76 OHARA S, HAGIHARA M, HUA J, INOUE M, .. | 1 0.01 97.77 OHARA S, YAMAZAKI J, NISHINO M, ET AL.. | 1 0.01 97.78 OHTAKA M, HATTORI Y, KUMANO Y, MAEDA .. | 1 0.01 97.79 OHTAKA M, HATTORI Y, KUMANO Y, MAEDA .. | 1 0.01 97.80 OKA A, YASUDA M, ISHIBUCHI H, KISHI C.. | 1 0.01 97.81 OKUMURA K, SHOJI F, YOSHIDA M, ET AL .. | 1 0.01 97.82 OLGA K, VALENA T, NOVOSAD J AND TERI .. | 1 0.01 97.83 OLIVER N, LUONG T, TCHAKAROV A, ABDEL.. | 1 0.01 97.84 OMOTO S, UTSUMI T, MATSUNO H, TERASAW.. | 1 0.01 97.85 ONDER A, OZTURK B, TATLI A AND KAYIKC.. | 1 0.01 97.86 ORTEGA CAMARERO MA, PINERO SAAVEDRA M.. | 1 0.01 97.87 OWAKI T, WADA Y, KUROSAWA Y, YAMAMOTO.. | 1 0.01 97.88 OYAMA, M.. INITIAL THERAPY FOR 28 CAS.. | 1 0.01 97.89 PAK L, KEMENY N, CAPANU M, CHOU J, BO.. | 1 0.01 97.90 PAPAXOINIS G, KOTOULA V, GIANNOULATOU.. | 1 0.01 97.91 PAPAXOINIS, G, KOTOULA V, GIANNOULATO.. | 1 0.01 97.92 PARASHAR, S.. TRIMETHOPRIM-SULFAMETHO.. | 2 0.02 97.94 PARK J, HWANG SR, WOO SH, YUN SK, KIM.. | 1 0.01 97.95 PASTORE S, LONDERO M, GORTANI G, ABAT.. | 1 0.01 97.96 PASTORE S, LONDERO M, GORTANI G, ABAT.. | 1 0.01 97.97 PASTORE S, LONDERO M, GORTANI G, ABAT.. | 1 0.01 97.98 PASTORE S, LONDERO M, GORTANI G, ABAT.. | 1 0.01 97.99 PATEL H, CAVANAGH Y, DEPASQUALE J. HY.. | 1 0.01 98.00 PAVLIDOU, E.. POSTERIOR REVERSIBLE EN.. | 1 0.01 98.01 PENAL P, GOSSET C, VERINE J, MOLINA J.. | 1 0.01 98.02 PENIT A, BEMER P, BESSON J, CAZET L, .. | 1 0.01 98.03 PETTIT NN, ALONSO V, WOJCIK E, ANYANW.. | 1 0.01 98.04 PEZZOLLA A., LATTARULO S., MANCUSI MA.. | 1 0.01 98.05 PILGRIM S, VELCHURU V, WATERS G, TSIA.. | 1 0.01 98.06 POGLIANI D, POZZI A, LAUDI C, RIMOLDI.. | 1 0.01 98.07 POGLIANI D, POZZI A, LAUDI C, RIMOLDI.. | 1 0.01 98.08 PONZETTI A, PINTA F, SPADI R, MECCA C.. | 1 0.01 98.09 PONZETTI AGOSTINO. JAW OSTEONECROSIS .. | 1 0.01 98.10 PRAT A, DE ANGELIS C, PASCUAL T, GUTI.. | 1 0.01 98.11 PRIEZ-BARALLON, C.. QUANTIFICATION OF.. | 1 0.01 98.12 PRIVACY P, LUGER A, LOACKER L, PIZZIN.. | 1 0.01 98.13 PROENCA P ET AL.. UPLCMS/ MS DETERMIN.. | 1 0.01 98.14 PROENCA P, FRANCO J, MUSTRA C, MONTEI.. | 1 0.01 98.15 PROVENZANI A, ET AL.. FATAL DRUG HYPE.. | 1 0.01 98.16 PUCHE MORENILLA C, CEBREIRO LOPEZ I, .. | 1 0.01 98.17 PUIG-COMAS G, GARCIA PELAEZ M, GORGAS.. | 1 0.01 98.18 QUIROGA B, BASTERRECHEA M, FERNANDEZ .. | 1 0.01 98.19 RABBONE I, GALDERISI A, TINTI D, IGNA.. | 1 0.01 98.20 RAFFEL J, GAFSON A, MALIK O, NICHOLAS.. | 1 0.01 98.21 RAI M, AHLBERG AW, MARWELL J, CHAUDHA.. | 1 0.01 98.22 RAKOTONARIVO L, LONS-DANIC D, JANIER .. | 1 0.01 98.23 RAMADAN AR, MEHTA C, HAWLEY M, VARELA.. | 1 0.01 98.24 RAMON, M.. HYPERCKEMIA INDUCED BY LEV.. | 1 0.01 98.25 RAPP J,YUEN M,ABRAHAM T. BRADYCARDIA .. | 1 0.01 98.26 RAPP, JH. BRADYCARDIA AFTER INTRAVENO.. | 1 0.01 98.27 REINA, D.. VISCERAL LEISHMANIASIS IN .. | 1 0.01 98.28 REPORTER KNOWN TO AUTHORITY. UNKNOWN... | 1 0.01 98.29 RIBEIRO BARBOSA, L. D.. EPIDIDYMITIS .. | 1 0.01 98.30 RIBEIRO BARBOSA, L.. EPIDIDYMITIS FOL.. | 1 0.01 98.31 RIZEK P, IKEDA K, MELE T, ET AL. BOWE.. | 1 0.01 98.32 RIZEK P, IKEDA K, MELE T, ET AL. BOWE.. | 1 0.01 98.33 RIZEK, P. BOWEL ISCHEMIA IN REFRACTOR.. | 1 0.01 98.34 RIZEK, P.. BOWEL ISCHEMIA IN REFRACTO.. | 1 0.01 98.35 ROBINSON DG, GALLEGO JA, JOHN M, PETR.. | 1 0.01 98.36 ROCCHI F, BAIARDI P, BARBIERI I, DEL .. | 3 0.03 98.39 ROCHE L, GULMAN C, O?KANE M. A CASE O.. | 1 0.01 98.40 RODRIGUEZ-MARCO NA, SOLANAS-ALAVA S, .. | 1 0.01 98.41 RODRIGUEZ-OSORIO X, PARDO J, LOPEZ-GO.. | 1 0.01 98.42 ROTA, E.. IATROGENIC COAGULOPATHY AND.. | 1 0.01 98.43 RUBINSTEIN A, CARPENTER DM. ELUCIDATI.. | 1 0.01 98.44 RUDEK M, DASARI A, LAHERU D, HE P, JI.. | 2 0.02 98.46 S. HASEGAWA, R. TOYA, AND H. KAWAMURA.. | 1 0.01 98.47 S. NARITA, Y. GOTO, S. MURAKAMI, Y.. .. | 1 0.01 98.48 SABURI M, YOSHIDA N, NAGAMATSU K, NAS.. | 1 0.01 98.49 SAEED NK. SALMONELLA PNEUMONIA COMPLI.. | 1 0.01 98.50 SAEED, N.. SALMONELLA PNEUMONIA COMPL.. | 1 0.01 98.51 SAINT-PIERRE MD, MORAN-MENDOZA O. ACE.. | 1 0.01 98.52 SAITO S. IN-USE EXPERIENCE OF NEW AND.. | 1 0.01 98.53 SALIBA F, DUVOUX C, DHARANCY S, DUMOR.. | 1 0.01 98.54 SALIBA F, DUVOUX C, DHARANCY S, DUMOR.. | 1 0.01 98.55 SANDHOLDT L, BYGUM A, R L. PROTON PUM.. | 1 0.01 98.56 SANDS, B.. THE EFFECT OF TOFACITINIB .. | 1 0.01 98.57 SANO, H.. PROPHYLACTIC ADMINISTRATION.. | 5 0.05 98.62 SARTORI D, CARVAJAL A.. QUETIAPINE AN.. | 1 0.01 98.63 SATO T, ET AL.. A CASE OF DIFFUSE WAL.. | 1 0.01 98.64 SATO, K.. A CASE OF CARDIAC ARREST CA.. | 1 0.01 98.65 SAWARMURA S, MAKINO T, JOHNO T, ET AL.. | 1 0.01 98.66 SCHAEFFER B, RUDEN L, SALZBRUNN T, PI.. | 1 0.01 98.67 SCHARL, A.. FATIGUE FOLLOWING ONCOLOG.. | 1 0.01 98.68 SCHIAVETTI A, VARRASSO G, COLLINI P, .. | 2 0.02 98.70 SCHIAVETTI A. VINCRISTINE, IRINOTECAN.. | 1 0.01 98.71 SCHWARZ, L.. HEMOPHAGOCYTIC SYNDROME:.. | 1 0.01 98.72 SCOTT AJ, DUNLOP A, BROWN A, SADLER C.. | 1 0.01 98.73 SEARS, S.. INCIDENCE OF SUSTAINED VEN.. | 1 0.01 98.74 SEDDEQ Y, ALGHAMDI S. FEATAL SEROTONI.. | 1 0.01 98.75 SERAFINI B, SCORSI E, ROSICARELLI B, .. | 1 0.01 98.76 SHAKUR R, KALER MK, HOWARD R.. QUETIA.. | 1 0.01 98.77 SHROFF R, VARADHACHARY G, BHOSALEP, U.. | 1 0.01 98.78 SIDDIQUE O, RASLA S, CLARK S AND KOKK.. | 1 0.01 98.79 SINGH P, SINHA A, KAMATH A, MALHOTRA .. | 1 0.01 98.80 SINGH, P.. VERY SEVERE APLASTIC ANAEM.. | 1 0.01 98.81 SKRABS. TREATMENT OF HBV-CARRYING LYM.. | 1 0.01 98.82 SODA, T.. A CASE OF PROSTATE CANCER A.. | 1 0.01 98.83 SON, J.. XANTHOGRANULOMATOUS OOPHORIT.. | 1 0.01 98.84 SONI P, KUMAR V, SARADNA A, KUPFER Y... | 1 0.01 98.85 SORKO S, LIND P, KOHLFURST S, MATSCHN.. | 1 0.01 98.86 SOULEN M, VAN HOUTEN D, DEITRICK G, S.. | 1 0.01 98.87 SPERL J, FRANKOVA S, KIESLICHOVA E, O.. | 1 0.01 98.88 SPERL J, FRANKOVA S, KIESLICHOVA E, O.. | 2 0.02 98.90 SPERL J, FRANKOVA S, KIESLICHOVA E, O.. | 1 0.01 98.91 STANTON N, GUPTA B, COLEMAN, H, SINGH.. | 1 0.01 98.92 STEFOSKI D. FIFTEEN NON-FATAL OUTCOME.. | 1 0.01 98.93 STEFOSKI D. IMMUNOSTIMULATORY EFFECT .. | 1 0.01 98.94 STILGENBAUER S, LEBLOND V, FOA R, BOT.. | 2 0.02 98.96 STRENGER V, MERTH G, LACKNER H, ABERL.. | 1 0.01 98.97 STRENGER V, MERTH G, LACKNER H, ABERL.. | 1 0.01 98.98 STRIZEK B, BERG C, GOTTSCHALK I, HERB.. | 1 0.01 98.99 STRUYE A, DEPUYDT C, SATER EA, DUBOI.. | 1 0.01 99.00 STRYJEWSKI TP, SCOTT NL, BARSHAK MB, .. | 3 0.03 99.03 SUITA K, SHIMIZU K, KANAZAWA T, MATSU.. | 1 0.01 99.04 SULIS ML, BLONQUIST TM, ATHALE UH, CL.. | 1 0.01 99.05 SUTTELS V. RHABDOMYOLYSIS-ASSOCIATED .. | 1 0.01 99.06 SVOJGR, K.. FANCONI ANEMIA WITH BIALL.. | 2 0.02 99.08 SWINNEN I, GHYS K, KERRE S, CONSTANDT.. | 1 0.01 99.09 SY A, ELIASIEH K AND SILKISS R. CLINI.. | 1 0.01 99.10 SY A, ELIASIEH K AND SILKISS R. CLINI.. | 1 0.01 99.11 SYLVIA MT, RANI J, BASU D, KAR R, DUB.. | 1 0.01 99.12 T ADACHI, Z TAKEDA, S NAKAYAMA, Y KAW.. | 1 0.01 99.13 T LEGUAY, C FOUCAUD, M PARRENS, O FIT.. | 1 0.01 99.14 T SUGIMOTO. ACUTE INTERSTITIAL NEPHRI.. | 1 0.01 99.15 TADA H, MIYASHITA M, GONDA K, WATANAB.. | 1 0.01 99.16 TAKAHASHI J, KUMAKURA M, OKAWA M, TOM.. | 1 0.01 99.17 TAKAHASHI N, NAKASEKO C, NISHIWAKI K,.. | 1 0.01 99.18 TAKAOKA T, HIRATA Y, MASUZAWA A, KOND.. | 1 0.01 99.19 TAKENAWA K, KOIKE Y, KUSANO W, KATO H.. | 1 0.01 99.20 TAMIYA M, SUZUKI H, SHIROYAMA T, ET A.. | 1 0.01 99.21 TAMIYA M, SUZUKI H, SHIROYAMA T, TANA.. | 1 0.01 99.22 TAMIYA M, SUZUKI H, SHIROYAMA T, TANA.. | 1 0.01 99.23 TANIKAWA K, MIZUNO K, MATSUYAMA H, ET.. | 1 0.01 99.24 TAORMINA SP, GALLOWAY MP, ROSENBERG D.. | 1 0.01 99.25 TAP WD, JONES RL, VAN TINE BA, CHMIEL.. | 1 0.01 99.26 TARAO K, YAMADA K. A HEPATITIS C VIRU.. | 1 0.01 99.27 TATTERSALL, R.. STIFF AND PARTIALLY B.. | 1 0.01 99.28 TEMPFER CB, CELIK I, SOLASS W, BUERKL.. | 1 0.01 99.29 TERADA S, YOSHIOKA H, KINOSHITA M, HA.. | 1 0.01 99.30 THALER HW, SCHMIDSFELD J, PUSCH M, PI.. | 1 0.01 99.31 THAUVIN-ROBINET, C., ROZE, E., COUVRE.. | 1 0.01 99.32 THOMAS J, ET AL.. MULTIPLE DRUGS : MA.. | 1 0.01 99.33 THOMAS J, WOLFF K. DIAGNOSIS OF NEONA.. | 1 0.01 99.34 THOMAS J, WOLFF K.. DIAGNOSIS OF NEON.. | 1 0.01 99.35 TOMITA A, SATANI M, SUZUKI K, KAJI A,.. | 1 0.01 99.36 TORRENTS R, BRUN R, SCHMITT C, BOULAM.. | 1 0.01 99.37 TORRENTS, R.. HYPOGLYCEMIA AND VOLUNT.. | 1 0.01 99.38 TOUZEAU C, MOREAU P. HOW I TREAT EXTR.. | 1 0.01 99.39 TROELSTRA N, RUTTEN A, DUISENBERG-VAN.. | 1 0.01 99.40 TSE S, OKIHIRO A, HASIJA R, FUNG L, C.. | 1 0.01 99.41 TSUKAMOTO, J. S.. TONIC-CLONIC SEIZUR.. | 1 0.01 99.42 TUCEK D, VELETA T, HAVRDA M. SAFER AN.. | 1 0.01 99.43 TUDESQ JJ, VINCENT L, LEBRUN J, HICHE.. | 1 0.01 99.44 TUNA KIRSACLIOGLU C, KULOGLU Z, USTUN.. | 1 0.01 99.45 TURATI, M.. OSTEOCHONDRAL ALTERATION .. | 1 0.01 99.46 UENO M, ET AL.. A CASE OF DIFFERENT S.. | 1 0.01 99.47 UGUZ F. GASTROINTESTINAL SIDE EFFECTS.. | 1 0.01 99.48 UNKNOWN, SINGH H, ANAND NAVIN, AND AH.. | 1 0.01 99.49 USLU U, HEPPT F, STICHERLING M. SECON.. | 1 0.01 99.50 VACCHIANO V, LIGUORI R, PASINI E, AVO.. | 1 0.01 99.51 VADEBONCOEUR, S.. FLAGELLATE PATTERN .. | 1 0.01 99.52 VALE-FERNANDES E, P?VOA AM, SOARES S,.. | 1 0.01 99.53 VALE-FERNANDES E, POVOA AM, SOARES S,.. | 1 0.01 99.54 VALENZUELA, F.. TOFACITINIB IN PATIEN.. | 1 0.01 99.55 VALKOVA M, STAMENOV B, PEYCHINSKA D, .. | 1 0.01 99.56 VALLERSNES. ADOLESCENT WITH RESPIRATO.. | 1 0.01 99.57 VATANKULU MA, TASAL A, ERDOGAN E, GOE.. | 3 0.03 99.60 VERONICA CARLINI. FUNGAL APPENDICITIS.. | 1 0.01 99.61 VIARD T, DESTEPHEN C, KARE M, LABADIE.. | 1 0.01 99.62 VIARD T, DESTEPHEN C, KARE M, LABADIE.. | 1 0.01 99.63 VICHIDO-LUNA M, MONTIJO-BARRIOS E, RA.. | 1 0.01 99.64 VIDALE, S.. ISCHEMIC STROKE AS UNUSUA.. | 1 0.01 99.65 VIVARD T., DESTEPHEN C., KARE M., LAB.. | 1 0.01 99.66 WADA M, NAKASUZI M, OKUTANI A, NAGAI .. | 1 0.01 99.67 WAKABAYASHI T, NATSUME A, MIZUSAWA J,.. | 1 0.01 99.68 WAKEYAMA E. A CASE OF SUSPECTED DRUG-.. | 1 0.01 99.69 WALKER, S. LACK OF EVIDENCE FOR SYSTE.. | 1 0.01 99.70 WALKER, S.. LACK OF EVIDENCE FOR SYST.. | 1 0.01 99.71 WARSZAWSKI J. OF CANCER IN CHILDREN P.. | 2 0.02 99.73 WEGNER, A.. NEUROSENSORY RETINAL DETA.. | 1 0.01 99.74 WEYAND AC, YANIK GA, BAILEY NG, WU Y,.. | 1 0.01 99.75 WHEDON JM, RUGO NA, LUX K. CHALLENGES.. | 1 0.01 99.76 WILLIAM I. LOW DOSE CONTINOUS 5-FLUOR.. | 1 0.01 99.77 WINDON A, MA Q, AARONS C, SHROFF S. I.. | 1 0.01 99.78 WOLLINA, U.. PEGYLATED LIPOSOMAL-ENCA.. | 1 0.01 99.79 WOODCOCK H, NELSON M. BURKITT^S NON-H.. | 1 0.01 99.80 WOODCOCK, H.. BURKITT^S NON-HODGKINS .. | 1 0.01 99.81 WU CY, MITCHELL SR, SEYFRIED LS. QUET.. | 1 0.01 99.82 XIONG H, LIU SY, YANG YX, TAN XX, LUO.. | 1 0.01 99.83 XIONG, H. A SMALL COHORT REVIEW OF TH.. | 1 0.01 99.84 XIONG, H.. AN UNUSUAL CASE OF ANAPLAS.. | 1 0.01 99.85 XU S, PONCE BA, PAVLIDAKEY PG, BRABST.. | 1 0.01 99.86 XU, S.. DRUG ERUPTION SECONDARY TO VA.. | 1 0.01 99.87 YAMAGUCHI T, YAMAGUCHI T, IMAIZUMI K,.. | 1 0.01 99.88 YAMAMOTO R, SAITO M, KAGAYA H, NUMAKU.. | 1 0.01 99.89 YIN MING KWAN, B., MANDELL D., BERNST.. | 1 0.01 99.90 YOKOYAMA T, MIYAZAWA K, KURAKAWA E, N.. | 1 0.01 99.91 YORULMAZ A, SAHIN E.B, SENER M, CAKMA.. | 1 0.01 99.92 YOSHIKAWA, H.. A CASE OF DRUG-INDUCED.. | 1 0.01 99.93 YU M, CHUA J. VIRUS-ASSOCIATED HAEMOP.. | 1 0.01 99.94 YU M, CHUA J. VIRUS-ASSOCIATED HAEMOP.. | 1 0.01 99.95 YUMA SAKURA, ET AL.. A CASE OF INTERS.. | 1 0.01 99.96 ZAFFANELLO M, BRUGNARA M, ANGELI S, C.. | 1 0.01 99.97 ZALESKI K, GORSKA A, KOLODZIEJ M, WIT.. | 1 0.01 99.98 ZERNA C,GUENTHER M,FOLPRECHT G,PUETZ .. | 1 0.01 99.99 ZOLLNER, G.. ALTERATIONS OF CANALICUL.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 8 Sep 2018